We are live on ! Find out more
CIM

Contravisory Investment Management Portfolio holdings

AUM $566M
1-Year Est. Return 42.93%
This Fund
S&P 500
This Quarter Est. Return
+13.37%
1 Year Est. Return
+42.93%
3 Year Est. Return
+129.34%
5 Year Est. Return
+198.47%
10 Year Est. Return
+603.03%
AUM
$322M
AUM Growth
+$28.8M
Cap. Flow
-$2.72M
Cap. Flow %
-0.84%
Top 10 Hldgs %
28.37%
Holding
285
New
38
Increased
61
Reduced
112
Closed
38

Top Buys

Rank Stock Value
1
ADSK icon
Autodesk
ADSK
+$5.66M
2
CGNX icon
Cognex
CGNX
+$5.61M
3
TREX icon
Trex
TREX
+$5.37M
4
UNP icon
Union Pacific
UNP
+$5.15M
5
ROK icon
Rockwell Automation
ROK
+$5.09M

Sector Composition

Rank Sector Weight
1 Technology 26.48%
2 Healthcare 17.99%
3 Financials 12.48%
4 Industrials 10.79%
5 Communication Services 8.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNPS icon
1
Synopsys
SNPS
$71.6B
$12.9M 4%
49,699
-1,520
-3% -$351K
ZBRA icon
2
Zebra Technologies
ZBRA
$13.5B
$10.7M 3.31%
27,761
-1,401
-5% -$471K
PYPL icon
3
PayPal
PYPL
$50.3B
$10.1M 3.13%
43,068
-1,098
-2% -$228K
MSFT icon
4
Microsoft
MSFT
$2.9T
$9.42M 2.92%
42,361
-60
-0.1% -$12.9K
ACN icon
5
Accenture
ACN
$106B
$9.4M 2.92%
35,994
+132
+0.4% +$31.6K
GRMN
6
Garmin
GRMN
$56.9B
$8.69M 2.7%
72,620
-457
-0.6% -$50.6K
TMO icon
7
Thermo Fisher Scientific
TMO
$214B
$8.12M 2.52%
17,434
-21
-0.1% -$9.85K
TMUS icon
8
T-Mobile US
TMUS
$195B
$7.94M 2.46%
58,890
+303
+0.5% +$37.4K
ABT icon
9
Abbott
ABT
$188B
$7.29M 2.26%
66,579
+188
+0.3% +$20.4K
ADSK icon
10
Autodesk
ADSK
$51.8B
$6.94M 2.15%
22,730
+21,472
+1,707% +$5.66M
UNH icon
11
UnitedHealth
UNH
$382B
$6.93M 2.15%
19,764
+109
+0.6% +$36.5K
MTD icon
12
Mettler-Toledo International
MTD
$28.1B
$6.93M 2.15%
6,079
-57
-0.9% -$62.5K
NEE icon
13
NextEra Energy
NEE
$184B
$6.89M 2.14%
89,292
+516
+0.6% +$38.6K
AMZN icon
14
Amazon
AMZN
$2.44T
$6.82M 2.12%
41,900
+260
+0.6% +$41.5K
ADBE icon
15
Adobe
ADBE
$105B
$6.77M 2.1%
13,529
+541
+4% +$261K
V icon
16
Visa
V
$701B
$6.74M 2.09%
30,808
-363
-1% -$74.3K
TGT icon
17
Target
TGT
$66.3B
$6.71M 2.08%
38,040
-166
-0.4% -$27.7K
GOOG icon
18
Alphabet (Google) Class C
GOOG
$4.11T
$6.65M 2.06%
75,880
+720
+1% +$60.7K
MCK icon
19
McKesson
MCK
$104B
$6.56M 2.03%
37,712
-121
-0.3% -$20.2K
ZTS icon
20
Zoetis
ZTS
$32.7B
$6.49M 2.01%
39,197
+248
+0.6% +$40.3K
MCO icon
21
Moody's
MCO
$83.7B
$6.46M 2%
22,258
-433
-2% -$121K
CGNX icon
22
Cognex
CGNX
$9.62B
$6.2M 1.92%
+77,192
New +$5.61M
COST icon
23
Costco
COST
$432B
$6.17M 1.91%
16,362
+55
+0.3% +$20.6K
NKE icon
24
Nike
NKE
$64.1B
$6.12M 1.9%
43,282
-205
-0.5% -$27.2K
TREX icon
25
Trex
TREX
$4.4B
$5.87M 1.82%
+70,128
New +$5.37M

Similar funds

Contravisory Investment Management's Q4 2020 Portfolio in Review

As of Q4 2020, Contravisory Investment Management held 285 positions worth $322M, up 9.8% from $293M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Contravisory Investment Management's Q4 2020 filing shows 38 new, 61 increased, 112 reduced and 38 closed positions. Its largest new stake was Cognex: 77,192 shares worth $6.2M. The largest sale was AbbVie, an estimated $6.39M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

  • Contravisory Investment Management's largest Q4 2020 buy was Cognex: 77,192 shares worth $6.2M.
  • Contravisory Investment Management added most to Autodesk in Q4 2020, an estimated $5.66M increase.
  • Contravisory Investment Management's biggest Q4 2020 reduction was AbbVie, cutting an estimated $6.39M.
  • Contravisory Investment Management fully exited Kimberly-Clark in Q4 2020, selling an estimated $6.15M.
  • Contravisory Investment Management's ten largest holdings make up 28% of its $322M portfolio in Q4 2020.
  • Contravisory Investment Management opened 38 new positions and closed 38 in Q4 2020.
  • Contravisory Investment Management's portfolio value rose 9.8% quarter-over-quarter to $322M.

Based on Contravisory Investment Management's 13F filing for Q4 2020, filed 13 Jan 2021.